Trials / Unknown
UnknownNCT04686916
Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients
A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial Studying the Efficacy and Safety of IP2018 in Young, Depressed, Erectile Dysfunction (ED) Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Initiator Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase IIa, randomised, double-blind, placebo-controlled, 3-period, crossover study to assess two single oral dose levels of IP2018. It is planned to enrol 24 patients. Patients will take part in three treatment periods, in which they will be randomised to receive either a single dose of IP2018 or a single dose of placebo in each treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IP2018 | Test drug |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2020-12-30
- Primary completion
- 2023-07-30
- Completion
- 2023-08-30
- First posted
- 2020-12-29
- Last updated
- 2023-03-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04686916. Inclusion in this directory is not an endorsement.